|thyroid cancer genetic||1.99||0.9||7280||1|
|thyroid cancer gene||0.09||0.7||5875||47|
|thyroid cancer genetic testing||0.77||0.9||721||13|
|thyroid cancer genetic mutation||0.77||0.1||7748||52|
|thyroid cancer genetic risk||1.8||0.8||9203||43|
|thyroid cancer genetic markers||1.04||0.4||8577||69|
|thyroid cancer gene test||0.67||0.4||2802||94|
|thyroid cancer gene mutation||0.72||1||9700||54|
|thyroid cancer genetic syndrome||1.67||0.3||6562||78|
|papillary thyroid cancer genetics||0.82||1||5768||25|
|medullary thyroid cancer genetics||1.45||0.7||8698||22|
|braf gene thyroid cancer||1.14||1||1385||75|
Underserved minorities and those with a low socioeconomic status (SES) present with more advanced disease and have worse outcomes for differentiated thyroid cancer, but this relationship has never been evaluated for medullary thyroid cancer (MTC).Can high thyroid antibodies mean cancer?
does high TPO antibodies mean cancer? The short answer is: No. Thyroid peroxidase (TPO) antibodies are a marker for the presence of autoimmune thyroid disease. Thyroid nodules are common with Hashimoto's and are associated with a small risk (5% to 7%) for thyroid cancer. Subsequently, question is, what is the treatment for high thyroid antibodies?Does heterogeneous thyroid leads to cancer?
Heterogenicity of thyroids indicates non-specific inflammation of the gland as seen in autoimmune thyroiditis. It does not per se lead to cancer, but the underlying pathology such as Vit D3 deficiency and environmental toxins can increase the risk. Hence one needs to convey this to the patients.